JM-010

DRUG2 trials

Sponsors

Bukwang Pharmaceutical, Contera Pharma A/S

Conditions

DyskinesiasLevodopa Induced Dyskinesia (LID)Parkinson's Disease

Phase 2

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

CompletedNCT02439203

Bukwang PharmaceuticalLevodopa Induced Dyskinesia (LID), Parkinson's Disease

Start: 2015-05-31End: 2016-01-31Updated: 2016-01-13

Open-Label Extension Study of ASTORIA

TerminatedNCT05516875

Contera Pharma A/SDyskinesias

Start: 2024-01-19End: 2024-06-27Updated: 2024-10-15

Related Papers

Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study

Movement Disorders2024-02-056 citations